The problem the study tackles is one of the most stubborn in cardiovascular medicine. Cardiac rehabilitation, which combines structured exercise, education, and psychosocial support, carries a Class IA recommendation in international guidelines for patients recovering from bypass surgery, and its benefits are well documented: better exercise capacity, improved cardiac function, and stronger psychological well-being. Yet participation remains dismal. Fewer than half of eligible patients in developed countries attend a program, and in developing nations the figure drops below 10 percent. The barriers are mundane but powerful: distance to the hospital, transportation costs, work schedules, and family obligations. Home-based telerehabilitation, delivered through wearable heart rate monitors, mobile applications, and periodic video or telephone consultations, has been proposed as a way around these obstacles, but rigorous real-world comparisons with careful confounding control have been scarce.

The research team screened the electronic health records of 288 adults aged 30 to 75 who underwent isolated CABG between February 2024 and February 2025, ultimately identifying 195 potentially eligible patients. After excluding 28 whose rehabilitation exposure could not be clearly documented, 167 patients formed the propensity-score estimation cohort: 56 who enrolled in home-based telerehabilitation, 54 in center-based rehabilitation, and 57 who received usual care without any formal program. The primary complete-case analysis then focused on the 105 patients, 35 per group, who completed full 12-week assessments. Because patients were not randomized, the investigators used generalized propensity scores and overlap weighting to adjust for 25 baseline covariates, ranging from age, sex, and body mass index to digital literacy, family support, distance to the rehabilitation center, and baseline fitness measures.

The home program itself was a carefully structured prescription rather than a casual suggestion to stay active. Patients received a wearable Polar H10 heart rate monitor paired with a dedicated mobile application and were asked to complete three aerobic sessions per week for 12 weeks, 36 sessions in total, each targeting 30 to 60 minutes of exercise at 60 to 80 percent of heart rate reserve, plus two weekly resistance training sessions. Intensity was progressed every two weeks based on heart rate response and perceived exertion on the Borg scale. Crucially, the researchers defined a session as completed only when at least 30 minutes of prescribed exercise at target intensity were objectively documented by the wearable device; app entries without valid sensor data did not count. Center-based patients attended the hospital’s outpatient program with the same prescription but under direct supervision with continuous ECG telemetry, and their adherence was verified through physiotherapist-signed attendance records and telemetry logs.

The headline result concerns adherence, the study’s primary implementation outcome. Patients in the home-based arm completed a mean of 87.7 percent of their prescribed sessions, compared with 78.5 percent in the center-based arm, an overlap-weighted difference of 9.1 percentage points with a 95 percent confidence interval of 4.4 to 13.7 and a P value below 0.001. The gap widened at the high end of the distribution: 78.6 percent of home-based patients achieved at least 80 percent completion, versus 44.4 percent of center-based patients, and 46.4 percent of the home group reached 90 percent or more, compared with just 13.0 percent of the center group. Home patients also logged more objectively verified exercise minutes overall, 1,578 versus 1,413, and more minutes at target intensity. Technical failures, such as lost or invalid wearable recordings, affected only 1.7 percent of prescribed home sessions.

On the key clinical outcome, the two delivery models proved remarkably close. Peak oxygen uptake, or VO2peak, measured by symptom-limited cardiopulmonary exercise testing on a cycle ergometer, rose from a baseline of roughly 18.3 to 18.4 mL/kg/min to about 23.1 to 23.6 mL/kg/min at 12 weeks in both rehabilitation groups. The adjusted difference between the home and center arms was a mere 0.17 mL/kg/min, with a confidence interval spanning −0.50 to 0.84 and a P value of 0.616, statistically indistinguishable from zero. Both active groups, however, dramatically outperformed usual care, which saw VO2peak inch up from 18.5 to 19.1 mL/kg/min; the adjusted advantages over control exceeded 4.0 mL/kg/min for both rehabilitation modalities. Given that lower VO2peak is strongly associated with increased mortality in cardiac populations, gains of that magnitude are clinically noteworthy.

Secondary outcomes told a consistent story. Six-minute walk distance improved by roughly 75 meters in both rehabilitation groups compared with control, with no meaningful difference between them. Left ventricular ejection fraction, measured by blinded readers using the biplane Simpson method, rose by about 4 to 5 percentage points in both active arms. Psychological measures moved in parallel: scores on the Hamilton Anxiety and Depression scales fell by 6 to 8 points in both rehabilitation groups while barely changing in usual care, and quality-of-life scores on the SF-36 physical and mental component summaries climbed by 16 to 22 points. Safety findings were reassuring in absolute terms: no major adverse cardiovascular events occurred in either rehabilitation group during the 12-week window, while two occurred among usual-care patients, though the small event counts precluded formal comparative safety inference. Exercise-related adverse events were uncommon and similar in character across both programs, including occasional chest pain, arrhythmia, and musculoskeletal complaints.

The investigators were careful about what their design can and cannot show. Because patients self-selected into each modality, unmeasured differences in motivation and preference may persist despite the extensive covariate adjustment, and the study was not powered or designed to formally test equivalence or non-inferiority between the two delivery models. Selection is a real concern: of the 195 potentially eligible patients, 46.2 percent were excluded from the complete-case analysis, and those excluded patients had fewer years of education, more frailty, lower employment rates, and markedly lower family support scores. The authors also note that the two delivery models differed not only in setting but in supervision intensity, with home patients exercising independently and receiving roughly 12 scheduled tele-consultations, so residual differences in how adherence was ascertained, device verification at home versus direct observation in center, cannot be fully excluded. Sensitivity analyses, including unweighted models, multiple imputation, restriction to a strict 11-to-13-week assessment window, and exclusion of crossovers, all produced directionally consistent estimates for the VO2peak comparison.

An exploratory analysis probing whether higher adherence drove better functional outcomes found a positive but non-significant association: each 10-percentage-point increase in adherence was associated with roughly 0.62 mL/kg/min greater VO2peak gain, with a confidence interval that just crossed zero. The authors explicitly caution against a causal reading, since healthier, more motivated, or faster-recovering patients may both complete more sessions and improve more, a classic healthy-adherer effect that observational data cannot untangle. The adherence-by-modality interaction was also non-significant, suggesting the adherence-outcome relationship did not differ meaningfully between the home and center programs.

What the study does establish is feasibility in routine practice. Among post-CABG patients who chose between the two options in a real clinical setting, home-based telerehabilitation delivered objectively verified adherence that exceeded center-based care and functional recovery that looked essentially identical at 12 weeks. For patients juggling work, travel, or caregiving obligations, the findings support offering a monitored home program as a legitimate alternative rather than a second-best compromise. The authors call for future work on clinical meaningfulness and cost-effectiveness, and longer follow-up will be needed to see whether early fitness gains translate into durable outcomes. But the message for the millions of bypass patients each year who cannot reach a hospital gym is clear: with a chest strap, a smartphone, and a structured prescription, the road to recovery may run straight through their living room.

Subject of Research: Home-based versus center-based cardiac rehabilitation adherence and functional outcomes after coronary artery bypass grafting

Article Title: Home-based telerehabilitation after CABG: higher objectively verified adherence and 12-week functional outcomes in a single-center observational cohort

Article References: Liu, Y., Wang, X., Wang, C., Zhang, M., Kong, M., Wang, M., Ma, J., & Liu, H. (2026). Home-based telerehabilitation after CABG: higher objectively verified adherence and 12-week functional outcomes in a single-center observational cohort. Frontiers in Cardiovascular Medicine, 13, Article 1947232. https://doi.org/10.3389/fcvm.2026.1947232

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1947232

Keywords: cardiac rehabilitation, coronary artery bypass grafting, telerehabilitation, wearable sensors, adherence, VO2peak, observational cohort, cardiovascular medicine, propensity score analysis, exercise capacity, digital health, patient recovery

The study, led by Jingyi Xie and Zhide Liang with corresponding author Bin Wang, pooled data from 7,760 participants with coronary heart disease across 129 randomised controlled trials. That scale matters. Individual trials of exercise in cardiac patients are often small, brief, and heterogeneous, making it difficult to compare one training modality against another with any statistical confidence. By using a network meta-analysis — a technique that simultaneously compares multiple interventions, both through direct head-to-head trials and indirect comparisons across the network of studies — the team could rank exercise modalities that had rarely, if ever, been tested against each other in the same experiment.

The outcome the researchers focused on was peak oxygen uptake, or VO₂peak, the maximum rate at which the body can consume oxygen during incremental exercise. Cardiologists prize this measurement because it integrates the performance of the entire oxygen transport chain: the lungs, the heart’s pumping capacity, the vasculature, and the oxidative machinery of skeletal muscle. In patients with coronary heart disease, higher VO₂peak consistently tracks with lower mortality, fewer hospitalisations, and better quality of life, which is why guidelines from bodies such as the American College of Sports Medicine place cardiorespiratory fitness at the centre of exercise prescription.

The headline finding is that most exercise modalities outperformed control conditions, but two stood out. Interval aerobic exercise training — sessions built around alternating periods of higher and lower intensity — produced a mean improvement of 3.43 millilitres per kilogram per minute in VO₂peak compared with control, with a 95 percent credible interval of 2.87 to 3.99. Combined aerobic and resistance exercise training came next, with a mean difference of 2.49 (95 percent credible interval: 1.81 to 3.17). For context, even modest gains in peak oxygen uptake on the order of one metabolic equivalent are associated with clinically meaningful reductions in cardiovascular risk, so differences of this magnitude across an entire rehabilitation population are far from trivial.

Why might interval training hold an edge? The physiological rationale is that repeated bouts near a patient’s tolerance impose a potent stimulus on both central cardiovascular function and peripheral muscle oxidative capacity, while the recovery intervals allow total work to accumulate without excessive fatigue. The combined-training result is similarly intuitive: resistance work complements aerobic conditioning by improving skeletal muscle strength and mass, which can raise the ceiling on whole-body oxygen consumption. But the authors are careful to temper these rankings. They report substantial heterogeneity across trials and describe the certainty of the modality-specific comparisons as low, meaning the ordering of interventions should be read as exploratory rather than definitive.

What sets this analysis apart from earlier meta-analyses is its second analytical engine. The team deployed a meta-analytic random forest, or MARF, a machine learning model trained on study-level characteristics to predict how large an exercise effect would be, and then interpreted the model using Shapley Additive Explanations, or SHAP. SHAP values, a technique rooted in cooperative game theory, quantify how much each feature — such as participant age, intervention length, or training intensity — contributes to each prediction. This approach lets researchers probe heterogeneity in a way traditional subgroup analyses cannot, revealing which variables genuinely drive differences between trials rather than merely appearing to.

The machine learning exploration converged on a clear signal: intervention length emerged as an influential study-level moderator of effect. In plain terms, longer programmes were associated with bigger improvements in fitness. This aligns with the biology of training adaptation, where structural and enzymatic remodelling of heart and muscle tissue accrues over weeks and months, not days. It also carries a practical warning for health systems that fund short courses of cardiac rehabilitation and then discharge patients, potentially cutting the adaptation curve short at its steepest point.

The dose-response analyses added further nuance. Using meta-regression models, the researchers found that greater weekly exercise dose was generally associated with larger improvements in VO₂peak — more volume, more benefit, at least across the range studied. Per-session dose, however, told a different story: the relationship was inverted-U-shaped, rising to a peak and then declining. That shape suggests there is an optimal amount of work per session beyond which additional load yields diminishing, or even counterproductive, returns — a pattern consistent with the idea that overly demanding single sessions may compromise quality, adherence, or safety in a cardiac population.

The authors frame their conclusions with deliberate caution. Exercise-based cardiac rehabilitation does improve VO₂peak in adults with coronary heart disease, they conclude, but the substantial heterogeneity and low-certainty evidence limit confidence in the precise ranking of modalities. They recommend that exercise dose and programme duration be considered alongside patient characteristics, comorbidity burden, and safety when designing rehabilitation programmes, and they stress that these exploratory, aggregate-level findings require prospective validation before they can guide individualised exercise prescriptions. Notably, the research received no specific external funding, and the authors declare no competing interests.

Even with those caveats, the study marks a methodological milestone. Pairing network meta-analysis with interpretable machine learning offers a template for how exercise science — a field drowning in small, heterogeneous trials — might extract more reliable guidance from the evidence it already has. For clinicians, the actionable takeaways are refreshingly concrete: favour interval-based aerobic work or combined aerobic-resistance programmes where feasible, extend programme duration where possible, and think in terms of weekly dose rather than pushing any single session to its limit. For patients, the message is simpler and older than any algorithm: the exercise you do consistently, at an appropriate dose, over a long enough period, is what reshapes the heart’s capacity — and with it, the odds of a longer life.

Subject of Research: Comparative effects of exercise modalities on peak oxygen uptake in coronary heart disease rehabilitation

Article Title: Exercise-based management of patients with coronary heart disease: an integrated network meta-analysis and machine learning exploration

Article References: Xie, J., Liang, Z., Wang, B., Cai, X., & Gan, Z. (2026). Exercise-based management of patients with coronary heart disease: an integrated network meta-analysis and machine learning exploration. BMC Medicine. https://doi.org/10.1186/s12916-026-05229-5

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05229-5

Keywords: coronary heart disease, cardiac rehabilitation, peak oxygen uptake, interval training, network meta-analysis, machine learning, random forest, SHAP, exercise dose-response, aerobic exercise, resistance training, VO2peak

Cardiorespiratory fitness is usually expressed as peak oxygen uptake, or VO2peak, the maximum rate at which the body can consume oxygen during incremental exercise. It is not merely a number for athletes. Across pediatric and adult populations, VO2peak is one of the strongest predictors of long-term cardiovascular health and all-cause mortality, and low fitness in adulthood tracks back to low fitness in childhood. For childhood cancer survivors, the stakes are even higher. Treatments that save lives, including anthracycline chemotherapy agents such as doxorubicin, chest-directed radiation, and certain targeted therapies, can impair cardiac contractility, reduce lung capacity, blunt the autonomic regulation of heart rate, and accelerate vascular aging. A landmark study by Lipshultz and colleagues in the New England Journal of Medicine as far back as 1991 documented late cardiac effects of doxorubicin in children treated for acute lymphoblastic leukemia, and subsequent work has repeatedly linked treatment exposure to measurable declines in exercise capacity.

The scale of the problem was quantified in a 2026 systematic review and meta-analysis by Weinkauf and colleagues in the European Journal of Preventive Cardiology, which pooled fitness data from childhood cancer survivors across multiple studies and found substantially reduced cardiorespiratory fitness compared with healthy peers. Earlier work by Caru and colleagues reached a similar and striking conclusion: survivors of childhood acute lymphoblastic leukemia had significantly lower fitness levels than healthy Canadians even when their self-reported physical activity levels were clinically equivalent. That dissociation is critical. It suggests that the fitness deficit is not simply a matter of survivors exercising less, but reflects underlying physiological impairment, whether cardiac, pulmonary, skeletal muscle mitochondrial, or autonomic, that only objective testing can reveal.

This is where cardiopulmonary exercise testing, commonly abbreviated as CPET, enters the picture. Unlike a simple treadmill time or a six-minute walk distance, CPET directly measures the exchange of oxygen and carbon dioxide at the mouth while the patient exercises on a cycle ergometer or treadmill with progressively increasing intensity. Breath-by-breath gas analysis, combined with continuous electrocardiography, blood pressure monitoring, and often pulse oximetry, allows clinicians to distinguish among the multiple organ systems that can limit exercise performance. A cardiac limitation, a ventilatory limitation, a peripheral muscular limitation, or simply poor effort each leaves a characteristic fingerprint in the CPET data. In a population where multiple organ systems may be quietly compromised by treatment, that diagnostic specificity is invaluable.

The technical foundations of modern CPET were established decades ago. The 1983 study by Buchfuhrer and colleagues in the Journal of Applied Physiology demonstrated how to optimize incremental exercise protocols so that the test lasts long enough to capture true maximal oxygen uptake but short enough to avoid fatigue-driven underestimation. Consensus statements from the American Thoracic Society and the American College of Chest Physicians in 2003, and from the European Association for Cardiovascular Prevention and Rehabilitation and the American Heart Association in 2012, codified how CPET data should be collected and interpreted in specific patient populations. Applied to children, the test is safe, well tolerated, and feasible even in patients treated for leukemia, as demonstrated in feasibility studies of post-chemotherapy leukemia patients published in Annals of Rehabilitation Medicine.

The evidence that CPET detects real, subclinical dysfunction in survivors is compelling. A 2020 study by Long and colleagues in Medicine and Science in Sports and Exercise showed that cardiovascular exercise testing uncovered underlying dysfunction in childhood leukemia survivors that standard resting assessments missed. Caru’s own work has shown that doxorubicin exposure induces significant changes in the cardiac autonomic nervous system of long-term survivors, alterations that manifest during the dynamic stress of exercise long before they would appear at rest. Because exercise places simultaneous demand on the heart, lungs, blood vessels, and muscles, it functions as a physiological stress test for the entire integrated system, exposing vulnerabilities that a resting echocardiogram or a routine checkup would never reveal.

The clinical significance of these measurements extends beyond diagnosis. Exercise intolerance in adult survivors of childhood cancer has been linked to mortality and organ system impairment in a major study by Ness and colleagues published in the Journal of Clinical Oncology, making fitness a genuine prognostic marker rather than a soft measure of wellbeing. If low VO2peak identifies survivors at elevated risk, it also creates a target for intervention. A 2026 meta-analysis by Van Ermengem and colleagues in the same journal, Supportive Care in Cancer, examined the impact of exercise interventions on cardiorespiratory fitness in childhood cancer survivors and found that structured training programs can improve fitness, echoing earlier meta-analyses of exercise interventions and cardiovascular health in childhood cancer. Randomized trials, including a dose-graded aerobic exercise regimen studied by Elnaggar and colleagues and a home-based program tested by Manchola-González and colleagues, have shown that carefully prescribed aerobic training improves cardiopulmonary fitness and physical functioning in pediatric survivors of acute lymphoblastic leukemia.

Translating those findings into practice requires qualified professionals. The authors emphasize the role of the exercise physiologist, a health professional with formal training in exercise science, exercise physiology, or kinesiology, often certified by recognized bodies such as the American College of Sports Medicine, who is qualified to conduct exercise testing, assess cardiovascular and metabolic responses, and prescribe individualized, evidence-based exercise programs. In a survivorship clinic, such a specialist can administer a CPET safely, interpret the ventilation and gas-exchange curves in the context of the patient’s specific treatment exposures, and convert the results into a training prescription with appropriate intensity, progression, and safety margins. Fitness gains in this population also ripple outward: research by Dubnov-Raz and colleagues has linked improvements in fitness to improvements in body composition and bone health in children after cancer, both of which are common sites of treatment-related harm.

Despite this accumulating evidence, CPET remains underused in routine pediatric oncology follow-up, where surveillance typically focuses on imaging, blood counts, and endocrine function. The authors’ argument is essentially a call to close the gap between what the literature shows and what clinics do. Objective measurement of cardiorespiratory fitness would allow clinicians to identify the most impaired survivors early, track their response to rehabilitation, and intervene before deficits compound into adult cardiovascular disease. It would also standardize outcome measures across trials of exercise interventions, making it easier to compare programs and establish dose-response relationships between training and health outcomes.

For a generation of survivors who will live decades beyond their diagnosis, the message is clear: the heart, lungs, and muscles that carried them through treatment need to be measured, monitored, and trained, not assumed healthy. Cardiopulmonary exercise testing offers a precise, safe, and scientifically validated window into the long-term physiological cost of curing childhood cancer, and, paired with structured exercise prescription, a practical pathway to repairing it. As the survivor population continues to grow, integrating this technology into standard survivorship care may prove to be one of the most consequential steps yet in ensuring that children who beat cancer do not simply survive, but thrive.

Subject of Research: Cardiopulmonary exercise testing to assess cardiorespiratory fitness in childhood cancer survivors

Article Title: Cardiopulmonary exercise testing to measure cardiorespiratory fitness in childhood cancer survivors

Article References: Caru, M., Wilson, R. L., Sholler, C., & Dieli-Conwright, C. M. (2026). Cardiopulmonary exercise testing to measure cardiorespiratory fitness in childhood cancer survivors. Supportive Care in Cancer, 34(10), Article 1068. https://doi.org/10.1007/s00520-026-11285-7

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11285-7

Keywords: cardiopulmonary exercise testing, cardiorespiratory fitness, childhood cancer survivors, VO2peak, pediatric oncology, anthracycline cardiotoxicity, exercise physiology, survivorship care, acute lymphoblastic leukemia, exercise interventions, cardiovascular health, Supportive Care in Cancer

The research, led by Ferdinand Anokwuru and Scott R. Bauer with colleagues at the Charles R. Drew University of Medicine and Science, the San Francisco Coordinating Center, the University of Pittsburgh, Wake Forest University, and other institutions, drew on baseline data from the Study of Muscle, Mobility and Aging, known as SOMMA. This cohort was designed to uncover the cellular biology behind age-related loss of mobility, and it gave the team an unusual opportunity. Rather than relying on questionnaires alone, the investigators measured the actual physiology of energy production and energy expenditure in 629 community-dwelling adults aged seventy and older, then asked whether those measurements tracked with the severity of lower urinary tract symptoms.

The technical core of the study rests on three quantities. The first is VO2peak, the maximum rate of oxygen consumption a person can achieve during a symptom-limited treadmill cardiopulmonary exercise test using a modified Balke protocol. This is the classic measure of cardiorespiratory fitness, the ceiling of the body’s aerobic engine. The second is the energetic cost of walking, abbreviated ECw, defined here as the average oxygen consumption while walking slowly at a fixed treadmill speed of 0.67 meters per second for five minutes. This captures how metabolically expensive it is for an individual to perform one of the most fundamental tasks of daily life. The third quantity is the cost-capacity ratio, or CCR, calculated as one hundred times the energetic cost of walking divided by VO2peak. In plain terms, the CCR expresses what fraction of a person’s total aerobic capacity is consumed simply by walking at a slow pace.

The logic behind the cost-capacity ratio is what makes this study conceptually striking. Two older adults can have identical walking costs but very different fitness levels, and two can have identical fitness levels but very different walking costs. Only the ratio captures the lived experience of effort. When the energy required to move approaches the energy available to move, every step feels harder, and the margin left over for everything else, including the physiological work of maintaining continence and bladder control, shrinks. The researchers hypothesized that this energetic squeeze might be visible in urinary symptoms, which previous work has repeatedly linked to mobility limitation, frailty, and functional decline.

To measure symptoms, the team used the 10-item LURN Symptom Index, a validated instrument that scores lower urinary tract symptoms over the past week on a scale from zero to thirty-eight, with higher scores indicating worse symptoms. They then fitted linear and logistic regression models relating VO2peak, ECw, and CCR to symptom scores and to the presence of urinary incontinence. Crucially, the models were adjusted for a demanding set of potential confounders: demographics, anthropometrics such as body size, smoking status, multimorbidity, and obstetric factors in women. The investigators also tested for interactions by sex, recognizing that the anatomy and physiology of the lower urinary tract differ substantially between men and women.

The results were nuanced but suggestive. In minimally adjusted models, both a higher energetic cost of walking and a higher cost-capacity ratio were associated with worse total scores on the LURN Symptom Index. For the cost-capacity ratio, each one standard deviation increase corresponded to a beta of 0.36 points on the symptom scale, with a ninety-five percent confidence interval of 0.05 to 0.67. When the models were fully adjusted for the complete set of confounders, however, the confidence intervals widened to include zero, meaning these overall associations could no longer be distinguished from chance. The authors are appropriately careful on this point: the evidence points toward a modest association rather than a dramatic one.

One finding did survive full statistical adjustment, and it is the most intriguing result in the paper. A higher energetic cost of walking was associated with significantly greater odds of urinary incontinence in men, with an odds ratio of 1.67 and a confidence interval of 1.10 to 2.54, but the same association was not observed in women. This sex-specific pattern raises questions the study was not designed to answer. In men, incontinence and other lower urinary tract symptoms often arise in the context of prostate enlargement and bladder outlet changes, and it is possible that a metabolically expensive gait pattern reflects underlying vascular or muscular deterioration that also compromises the systems supporting urinary control. In women, obstetric history and pelvic floor mechanics may dominate the symptom picture in ways that swamp any energetic signal.

Notably, VO2peak by itself was not associated with lower urinary tract symptoms in any of the adjusted models. This null result is informative. It suggests that raw aerobic capacity, the sheer size of the engine, matters less than the relationship between that capacity and the cost of using it. A person with a modest VO2peak who walks efficiently may fare as well symptomatically as someone with a larger engine and a costlier gait. This reframing matters for intervention design, because it implies that reducing the energetic cost of walking, through gait retraining, weight management, or improved muscle mitochondrial function, could be as meaningful as raising fitness itself.

The study builds on a growing body of SOMMA research connecting energetics to aging outcomes. Earlier work from the same cohort has shown that lower muscle mitochondrial energetics are associated with greater phenotypic frailty and with multimorbidity burden, and that walking energetics and perceived fatigability interact with gait speed. Prior epidemiological studies have also linked physical activity to urinary health, finding that higher activity levels are associated with lower risk of urinary incontinence in women and reduced lower urinary tract symptom risk in men, while obesity increases risk. The new analysis adds a mechanistic dimension to this literature by proposing a specific physiological pathway, the cost-capacity relationship, through which overall physical condition and urinary symptoms could be connected.

The authors are candid about the limitations. The data are cross-sectional, so the direction of the relationship cannot be established. It is entirely possible that severe urinary symptoms, particularly nocturia that fragments sleep or incontinence that discourages leaving home, lead to reduced physical activity, deconditioning, and a rising cost-capacity ratio rather than the reverse. The associations, where they existed, were modest, and the fully adjusted models attenuated several of them. Still, the paper’s central proposal is compelling: energetic capacity, the balance between what movement costs and what the body can supply, may represent a novel intervention target for the large population of older adults in whom lower urinary tract symptoms and mobility limitations occur together. If future longitudinal and experimental studies confirm the pathway, the humble treadmill walk test could become an unexpected window into urinary health in aging.

Subject of Research: Associations between walking energetics, cardiorespiratory fitness, and lower urinary tract symptoms in older adults

Article Title: Energetic pathway to lower urinary tract symptoms in older adults: associations with cardiorespiratory fitness and walking energetics in the study of muscle, mobility and aging

Article References: Anokwuru, F., Mansfield, T. A., Chen, B. H., Glynn, N. W., Mau, T., Kritchevsky, S. B., McVary, K., Gill, H. K., Barnes, H. N., Goodpaster, B. H., Cummings, S. R., Cawthon, P. M., & Bauer, S. R. (2026). Energetic pathway to lower urinary tract symptoms in older adults: associations with cardiorespiratory fitness and walking energetics in the study of muscle, mobility and aging. GeroScience. https://doi.org/10.1007/s11357-026-02524-0

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02524-0

Keywords: lower urinary tract symptoms, urinary incontinence, aging, cardiorespiratory fitness, VO2peak, walking energetics, cost-capacity ratio, GeroScience, SOMMA, geriatrics, mobility, energy metabolism

The scientific rationale behind the study is deceptively simple. Most research on aging is confounded by inactivity. In England, roughly ninety percent of adults aged seventy-five and above fail to meet recommended guidelines for aerobic and muscle-strengthening exercise, which means that when scientists measure functional decline in typical older populations, they cannot tell how much of the deterioration reflects intrinsic biological aging and how much reflects disuse. The London cyclists were recruited precisely to break that confound. At baseline, participants had to be healthy, free of diagnosed cardiovascular, musculoskeletal or neurological conditions, and training at levels the researchers considered at or above a theoretical set point for healthy aging. By studying people who maintained this activity over nine years, the team hoped to glimpse a model of inherent biological aging, largely unmasked by the negative effects of a sedentary lifestyle.

The primary outcome was peak oxygen uptake, or VO2peak, the gold-standard measure of cardiorespiratory fitness and one of the strongest single predictors of all-cause mortality. The numbers tell a striking story. Across the cohort, VO2peak fell from 44.1 to 35.4 millilitres per kilogram per minute, a decline of 19.7 percent, equivalent to roughly 2.2 percent per year. That figure is considerably steeper than what cross-sectional studies of the general population would predict, with meta-analyses suggesting annualized declines of less than one percent even in sedentary individuals, and around 0.7 percent in master athletes. The discrepancy matters. It suggests that cross-sectional snapshots systematically underestimate the true speed of physiological aging, and that only by following the same individuals over time can researchers capture the real trajectory.

Part of the explanation lies in training volume. Self-reported monthly cycling volume dropped by 33.5 percent over the nine years, and actigraphy worn on the ankle showed small declines in daily light and moderate activity, although sedentary time actually decreased and hard or very hard activity remained unchanged. Intriguingly, neither the change in training volume, nor physical activity levels, nor age itself correlated with the size of an individual’s fitness decline. The researchers also invoke the set point theory of exercise and aging: a hundred-kilometre ride at a given pace for a fifty-five-year-old may represent the same relative physiological challenge as a slower seventy-kilometre ride for an eighty-five-year-old. In other words, absolute training loads fall with age, but the relative stimulus may be preserved, and the fitness values these cyclists retained suggest they remained above the threshold where inactivity begins to erode function.

Benchmarking against the FRIEND reference database made the point vividly. When the cyclists’ follow-up VO2peak values were compared with large age-matched reference populations tested using identical cycle-ergometry criteria, every participant who completed the test except one ranked at or above the ninetieth percentile for their age and sex. Even those who had developed significant illness in the intervening years remained, physiologically, in the top decile of their peers. The mechanistic story behind the decline is also informative: maximum heart rate fell by eleven beats per minute, oxygen pulse dropped, and the ventilatory equivalent for carbon dioxide rose, indicating reduced ventilatory efficiency. When VO2peak was normalized to lean tissue mass rather than total body mass, the decline shrank to 13.7 percent, showing that loss of metabolically active muscle accounted for a meaningful share of the apparent fitness loss.

That body-composition shift was one of the study’s most notable findings. Total body mass and BMI stayed essentially stable across nine years, yet dual-energy X-ray absorptiometry revealed an 8.1 percent loss of lean tissue mass alongside a 20 percent increase in fat mass, pushing average body fat from 23.8 to 29.2 percent. Because these changes occurred in people exercising at high levels, the authors argue that a component of age-related body-composition change must reflect inherent biological aging rather than disuse alone, though reduced training volume and small dietary shifts, including a modest fall in protein intake, cannot be excluded as contributors. The finding carries a practical message: cycling delivers powerful aerobic benefits, but progressive resistance training remains the exercise of choice for preserving muscle mass and strength in older adults, as current physical activity guidelines emphasize.

Not every system declined in lockstep. Resting blood pressure remained unchanged, and fasting metabolic indices, including cholesterol, glucose and insulin, stayed within normal clinical ranges, with total and LDL cholesterol actually falling slightly. Lung function, measured by spirometry, declined more than cross-sectional data would predict, although values remained at or above age-predicted norms. Sleep quality, assessed with the Pittsburgh Sleep Quality Index, did not deteriorate at all, consistent with evidence linking physical activity to better sleep in older people. Measures of submaximal function were also relatively resilient: the ventilatory threshold fell by 14.8 percent relative to body mass but only 8.4 percent relative to lean mass, and it actually rose as a percentage of VO2peak, from 76.7 to 81.8 percent. Oxygen uptake kinetics, the speed at which the cardiorespiratory system responds to a step change in workload, slowed by fifteen percent, yet the overall pattern suggests the capacity to sustain everyday submaximal exercise is better preserved with active aging than maximal capacity.

Perhaps the most human dimension of the study emerged when the researchers classified participants by their returning health status. Thirty-five were optimal agers, still meeting the original strict health criteria; twenty-four were successful agers with no more than two well-controlled conditions; and twenty-three had compromised health, dominated by cardiovascular disease, which accounted for twenty-two of the twenty-three cases. Despite these differences, the physiological trajectories of the three groups were remarkably similar over nine years. The compromised-health group did lose fitness faster, 24.2 percent versus 17.3 percent in the optimal agers, likely reflecting cardiovascular pathology and treatments such as beta blockers and pacemakers that blunt maximum cardiac output. Yet even here, the benchmark against reference populations held: all but one participant remained at or above the ninetieth percentile. Successful agers were physiologically indistinguishable from those entirely free of disease.

The authors are careful about the caveats. Forty-three of the original 125 participants did not return, including eight confirmed deaths, and those who dropped out had higher baseline systolic blood pressure, lower lean mass and lower alcohol consumption than the optimal agers. The retained sample is therefore enriched for the healthiest survivors, and the decline observed in the compromised-health group is likely a conservative estimate. Equipment was replaced with closely matched models, cross-calibrated where necessary, and anchor blood samples confirmed that laboratory changes did not drive the metabolic findings. Female participants, all post-menopausal at both timepoints, showed aging trajectories largely similar to the males, with differences mostly disappearing after normalization to body or lean mass, supporting endurance exercise as an effective strategy for post-menopausal women.

The takeaway is both humbling and empowering. Even in people who cycled for a decade into their seventies and eighties, fitness fell, muscle melted away, fat crept upward and lungs stiffened, at rates that cross-sectional studies had badly underestimated. But against that backdrop of inevitable decline, sustained exercise kept every measured index within the realm of aging physiology rather than pathophysiology, and it did so even in those who developed serious disease along the way. Exercise, the study makes clear, is not a guarantee of disease-free aging, and older endurance athletes may face their own cardiovascular risks. What it does appear to guarantee, for those who keep moving, is a body that continues to perform at the very top of what its age allows, a protective effect on physiological function that persisted through nine years, several diagnoses, and the relentless arithmetic of growing older.

Subject of Research: Longitudinal physiological aging and cardiorespiratory fitness in highly active older cyclists

Article Title: A 9-year longitudinal investigation into physiological aging in highly active older adults

Article References: Fathi, A. S., Francis, T., Milbourn, E., Newton, E., Siegel, L., Taylor, S., Duggal, N. A., Lord, J. M., Lazarus, N. R., Pollock, R. D., & Harridge, S. D. R. (2026). A 9-year longitudinal investigation into physiological aging in highly active older adults. GeroScience. https://doi.org/10.1007/s11357-026-02483-6

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02483-6

Keywords: aging, exercise, cardiorespiratory fitness, VO2peak, cyclists, body composition, lean tissue mass, longitudinal study, geroscience, cardiovascular disease, healthy aging, physical activity

The research team, led by investigators at Trinity College Dublin and collaborating institutions, focused on two distinct but related markers of exercise tolerance. The first was peak oxygen uptake, or VO2peak, the maximal amount of oxygen the body can consume during incremental exercise to exhaustion. VO2peak is not merely a laboratory curiosity; it is one of the strongest independent predictors of cardiovascular and all-cause mortality, and people with type 2 diabetes consistently show reductions of roughly twelve to twenty-two percent compared with healthy peers. The second marker was the time constant of the primary phase of the oxygen uptake response, abbreviated as tau VO2p, which describes how quickly oxygen consumption rises toward its steady state when a person transitions from rest to moderate exercise. Slower kinetics mean a larger oxygen deficit at the onset of activity, greater reliance on anaerobic metabolism, and earlier fatigue during everyday tasks such as climbing stairs or carrying groceries.

Participants were stratified into two age cohorts: an early middle-aged group aged thirty-seven to fifty-nine years and a late middle-aged group aged sixty to seventy years. All had been diagnosed with type 2 diabetes for fewer than ten years and had glycated hemoglobin values below ten percent, indicating reasonably well-controlled disease. After an initial treadmill electrocardiogram stress assessment, volunteers were assigned to one of four groups: exercising or non-exercising controls in each age band. The allocation was not random, primarily because of differences in participants’ ability to travel to the training facility, a limitation the authors acknowledge. Those in the exercise arms completed a twelve-week supervised program of up to thirty-six sessions, combining continuous cycling at seventy to eighty percent of maximal heart rate, resistance training for major upper and lower body muscle groups at sixty to seventy percent of one-repetition maximum, core strengthening, flexibility work, and brief high-intensity intervals at approximately ninety percent of maximal heart rate. Adherence was exceptional, with participants averaging thirty-five of a possible thirty-six sessions.

The testing protocol was rigorous. Before and after the intervention, participants performed a graded exercise test on a cycle ergometer to determine VO2peak, peak power output, the power output at the gas exchange threshold, and the oxygen pulse, an indirect marker of stroke volume. In a separate session, they completed six constant-load cycling bouts at a workload corresponding to eighty percent of their individually determined gas exchange threshold, with breath-by-breath gas exchange measured continuously. Cardiac output was assessed by an inert gas rebreathing technique at rest and at thirty and two hundred forty seconds of exercise, allowing the researchers to calculate stroke volume, mean arterial pressure, and systemic vascular conductance. The oxygen uptake data were fitted with monoexponential or biexponential mathematical models to extract the time constant of the primary response, the parameter that captures how efficiently the oxidative system adjusts to a sudden metabolic demand.

The results were unambiguous for the exercising groups. Both the early and late middle-aged training cohorts showed statistically significant increases in absolute and relative VO2peak, rising from roughly twenty-five milliliters per kilogram per minute at baseline to about twenty-eight after training, an improvement of approximately twelve percent. Peak power output, the power output at the gas exchange threshold, and oxygen pulse all rose in parallel, while heart rate at exhaustion was unchanged, indicating genuine physiological adaptation rather than simply greater effort or familiarization with the test. Crucially, the magnitude of these gains did not differ between the two age groups. The non-exercising controls, by contrast, showed no meaningful changes in any of these variables over the twelve weeks, and body mass and HbA1c remained stable across all groups, meaning the fitness improvements could not be attributed to weight loss or better glycaemic control.

The oxygen uptake kinetics data told a similarly encouraging story. The time constant of the primary VO2 response fell from approximately forty seconds at baseline to around thirty-four to thirty-five seconds after training in both exercise groups, representing an acceleration of roughly twelve percent in the late middle-aged cohort and twenty-one percent in the early middle-aged cohort. Although the numerical difference between the age groups was noticeable, statistical testing showed it did not reach significance, and the authors concluded that the improvement in submaximal oxygen kinetics was essentially equivalent across ages. This matters because faster kinetics reduce the oxygen deficit at the start of exercise, limit the accumulation of metabolites that contribute to fatigue, and translate directly into better tolerance of the repetitive, moderate-intensity activities that define daily life, an effect that is particularly relevant for adults in their sixties who may be approaching the threshold of functional decline.

Perhaps the most intriguing mechanistic finding was what did not change. The researchers had hypothesized that faster oxygen uptake kinetics might be driven by improved central cardiovascular delivery of oxygen, reflected in more rapid adjustments of cardiac output, stroke volume, or systemic vascular conductance during the first seconds of exercise. Instead, when they quantified the dynamic responses of these variables by comparing the change at thirty seconds with the change at two hundred forty seconds, they found no significant alterations following training in either age group. The improvements in cardiac output and vascular conductance that were observed at fixed time points largely reflected the higher workloads participants could sustain after training rather than a fundamentally altered cardiovascular response profile. This pattern suggests that the acceleration of oxygen uptake kinetics was more likely mediated by peripheral adaptations, such as enhanced matching of oxygen delivery to metabolic demand within the contracting skeletal muscle, improved vasodilatory capacity, or better dynamic microvascular function, although the study did not directly measure muscle oxygenation.

The clinical implications are considerable. Type 2 diabetes prevalence rises sharply with age, and as populations grow older and more sedentary, the burden of the disease is projected to escalate. Previous work by the same group had shown that middle-aged adults with diabetes in their forties and fifties exhibit slowed oxygen uptake kinetics compared with healthy controls, whereas those in their sixties do not, hinting that age might modify the exercise phenotype of the disease. The new data extend that picture by demonstrating that, regardless of these baseline differences, the responsiveness to structured training, in both maximal and submaximal measures of exercise tolerance, is preserved across early and late middle age. In practical terms, clinicians can reasonably expect a sixty-three-year-old with well-controlled type 2 diabetes to gain as much fitness from a twelve-week combined program as a fifty-four-year-old with the same disease duration, which argues strongly against the assumption that older middle-aged patients are somehow less trainable.

The authors are careful to note the boundaries of their conclusions. The participants had relatively mild, uncomplicated diabetes with mean HbA1c values between 6.3 and 7.0 percent, so the findings may not generalize to people with poorer glycaemic control or advanced disease, who typically show greater impairments in fitness. The age gap between the two cohorts was only about ten years, limiting inferences about broader age-related differences in trainability, and the sex distribution differed between groups, although prior evidence indicates that training adaptations in VO2peak and oxygen kinetics are not influenced by sex in type 2 diabetes. The inert gas rebreathing technique also lacked the temporal resolution to detect subtle changes in central hemodynamics. Even so, the study provides a valuable benchmark for expected training responses in adults with type 2 diabetes in their forties through sixties, and it reinforces a message that exercise physiologists have long championed: the aging body, even one carrying a metabolic disease, retains a striking capacity to grow fitter when given the right stimulus. Whether the same plasticity extends to people over seventy or with longer disease duration remains an open and clinically urgent question.

Subject of Research: Effects of structured exercise training on cardiorespiratory fitness and oxygen uptake kinetics in early versus late middle-aged adults with type 2 diabetes

Article Title: Exercise training improves cardiorespiratory fitness and oxygen uptake kinetics to a similar extent in early and late middle‐aged adults with type 2 diabetes

Article References: Kiely, C., O'Connor, E., O'Shea, D., Green, S., & Egaña, M. (2026). Exercise training improves cardiorespiratory fitness and oxygen uptake kinetics to a similar extent in early and late middle‐aged adults with type 2 diabetes. Physiological Reports, 14(18), Article e71107. https://doi.org/10.14814/phy2.71107

Image Credits: AI Generated

DOI: 10.14814/phy2.71107

Keywords: type 2 diabetes, exercise training, cardiorespiratory fitness, oxygen uptake kinetics, VO2peak, middle age, cardiac output, skeletal muscle, aging, physical activity, Physiological Reports, vascular function